RBCL Financials 07/16/2014 02:15:23 RBC Life Scie

RBCL Financials 07/16/2014 02:15:23
RBC Life Sciences, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 25,471 25,160 28,448 28,157
Cost of Revenue 13,459 12,528 14,132 14,471
Gross Profit 12,012 12,632 14,316 13,686
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 12,130 12,581 13,946 12,166
Non-Recurring Items - - - -
Other 506 515 440 476
Operating Income (625) (464) (71) 1,044
Income From Continuing Operations
Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax (625) (464) (71) 1,044
Interest Expense 112 126 140 153
Earnings Before Tax (736) (590) (211) 891
Income Tax (236) (228) (139) 333
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (500) (361) (71) 558
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (500) (361) (71) 558
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (500) (361) (71) 558